Rexulti Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

Brexpiprazole (Rexulti) tablets have markings on one side, and are available in the following strengths and package configurations (see Table 1).

Click on icon to see table/diagram/image

Brexpiprazole, an atypical antipsychotic, is available as Brexpiprazole (Rexulti) tablets. Brexpiprazole is 7-{4-[4-(1-Benzothiophen-4-yl)piperazin-1-yl]butoxy}quinolin-2(1H)-one. The empirical formula is C₂₅H₂₇N₃O₂S and its molecular weight is 433.57.
Brexpiprazole (Rexulti) tablets are for oral administration and are available in 500 mcg, 1 mg, 2 mg, 3 mg and 4 mg strengths.
Excipients/Inactive Ingredients: Lactose monohydrate, corn starch, microcrystalline cellulose, hydroxypropyl cellulose, low-substituted hydroxypropyl cellulose, magnesium stearate, hypromellose, and talc.
For color: Titanium dioxide, iron oxide and ferrosoferric oxide.

brexpiprazole

Manufacturer:

Otsuka (Philippines)

Distributor:

Otsuka (Philippines)